NEW YORK (GenomeWeb News) – A new consortium has been launched in Europe with the goal of developing a handheld molecular diagnostic device to test for malaria.

The Nanomal project is led by researchers at St. George's, University College London and molecular diagnostics firm QuantuMDx and has been provided with funding of €5.2 million ($6.7 million) from the European Commission's Seventh Framework Programme. Other participants in the consortium include the University of Tuebingen in Germany and the Karolinska Institute in Sweden.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.